Glenmark Pharmaceuticals Limited Logo

Glenmark Pharmaceuticals Limited

NSE-GLENMARK
National Stock Exchange of India NYSE
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#3127
Country Rank
n/a
Market Cap
5.23 B
Price
18.53
Change (%)
0.34%
Volume
940,265

NSE-GLENMARK's Next Dividend

Next Estimated Amount
₹2.5
Next Estimated Pay Date
10/26/2025
Last Amount
₹2.5
Last Pay Date
10/27/2024
Dividend Shot Clock Ex-Date: 09/13/2024
0
Days
0
Hours
0
Minutes
0
Seconds
Ex-dividend date passed

Glenmark Pharmaceuticals Limited Dividend Chart

*Amounts are shown in the stock exchange currency (INR) for convenience

Glenmark Pharmaceuticals Limited(NSE-GLENMARK) Dividend History

Glenmark Pharmaceuticals Limited (NSE-GLENMARK) currently pays an annual dividend of $2.50 per share, offering a dividend yield of 0.16%. The next dividend payout date has not been announced.
Ex-Dividend Date Adj. Amount Record Date Pay Date Change (%)
2024 ₹2.5 0%
09/13/2024 ₹2.5 09/16/2024 10/27/2024 0%
2023 ₹2.5 0%
09/18/2023 ₹2.5 09/18/2023 10/29/2023 0%
2022 ₹2.5 0%
09/12/2022 ₹2.5 09/13/2022 10/27/2022 0%
2021 ₹2.5 0%
09/08/2021 ₹2.5 09/09/2021 10/24/2021 0%
2020 ₹2.5
09/17/2020 ₹2.5 09/18/2020 10/29/2020
*Amounts are shown in the stock exchange currency (INR) for convenience
*Historical information is adjusted for stock splits

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.